new glp-1 agonists receptor show promise in treating substance use disorders Mechanism of action of GLP-1

15 Deficiencies in insulin receptor activation, insulin availability, and insulin receptorrelated mechanisms may contribute to neurodegenerative conditions such as Alzheimer disease

Diabetes Obes Metab (2021) 23(9):21946

Its all critical, very important and a major contribution to the science, he said

CKD: Chronic Kidney Disease

Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP

News-Medical+3EurekAlert!+3ASMBS+3 To put numbers on it: Surgical patients lost ~58 lbs in two years ( 24% of total body weight, or TBW) GLP-1 patients lost only ~12 lbs ( 4.7% TBW) over the same period EurekAlert!+2News-Medical+2 Even among GLP-1 users who continued therapy for a full year, weight loss averaged only ~7% TBWstill far less than surgical outcomes EurekAlert!+2ASMBS+2 Another rigorous analysis published in JAMA Surgery compared weight loss surgery and GLP-1 receptor agonists over two years